Multi-dimensional attention framework for personalized Alzheimer's disease progression prediction across sporadic and genetic risk cohorts
Song, Z.; Morgan, S. E.; Zaman, S.
Show abstract
Alzheimers disease manifests through heterogeneous progression patterns across diverse populations, yet current predictive models fail to capture this complexity while maintaining clinical interpretability. Here we present a multi-dimensional attention framework that simultaneously captures temporal dynamics and biomarker importance patterns to predict disease progression across three fundamentally different populations: the general late-onset population using the Alzheimers Disease Prediction Of Longitudinal Evolution (TADPOLE) dataset (N=1669), cases with Down Syndrome-associated Alzheimers disease using the Alzheimers Biomarker Consortium - Down Syndrome (ABC-DS) dataset (N=396) and cases with autosomal dominant Alzheimers disease using the Dominantly Inherited Alzheimer Network (DIAN) dataset (N=425). Our framework achieved multi-class area under the ROC curve (mAUC) values of 0.793 (TADPOLE), 0.680 (ABC-DS) and 0.902 (DIAN) when trained on each dataset independently to predict individuals future diagnostic status (cognitively normal, mild cognitive impairment, or Alzheimers disease) based on their longitudinal biomarker history, outperforming conventional approaches. The model generates individual-specific attention maps revealing distinct biomarker importance over time. Transfer learning from the TADPOLE dataset-which included neuroimaging data-improved prediction performance on the ABC-DS dataset with no neuroimaging data included from 0.680 to 0.771, demonstrating that disease mechanisms transcend both etiological boundaries and data modalities. Ultimately this framework could help enable precision medicine approaches for data-limited cohorts across the Alzheimers disease spectrum.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Comparison and aggregation of event sequences across ten cohorts to describe the consensus biomarker evolution in Alzheimer’s disease 97%
- Early Syndecan-4 Upregulation Predicts Cognitive and Pathological Trajectories in Alzheimer Disease 95%
- Polygenic effects on the risk of Alzheimer’s disease in the Japanese population 94%
Similar papers in this journal
Similar papers in this journal
- Investigating the Amyloid-Tau-Neurodegeneration Framework in Alzheimer's Disease Using Semi-Supervised Multimodal Imaging Data Fusion 96%
- NeuropsychBrainAge: a biomarker for conversion from mild cognitive impairment to Alzheimer’s disease 95%
- Delayed primacy recall performance predicts post mortem Alzheimers disease pathology from unimpaired ante mortem cognitive baseline 95%
Similar papers in this journal
- Using Machine Learning and Electronic Health Record (EHR) Data for the Early Prediction of Alzheimer’s Disease and Related Dementias 94%
- Continuous Associations Between Remote Self-Administered Cognitive Measures and Imaging Biomarkers of Alzheimer’s Disease 93%
- A conformational variant of p53 (U-p53 AZ ) as blood-based biomarker for the prediction of the onset of symptomatic Alzheimer’s disease 93%